v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 208,440 $ 184,550
General and administrative 176,205 67,504
Total operating expenses 384,645 252,054
Loss from operations (384,645) (252,054)
Interest income 13,900 12,682
Interest expense (6,893) (6,837)
Other expense, net (301) (85)
Total other income (expense), net 6,706 5,760
Net loss $ (377,939) $ (246,294)
Net loss per share, basic (in dollars per share) $ (3.29) $ (2.47)
Net loss per share, diluted (in dollars per share) $ (3.29) $ (2.47)
Weighted average common shares outstanding, basic (in shares) 114,701,154 99,838,102
Weighted average common shares outstanding, diluted (in shares) 114,701,154 99,838,102
Comprehensive loss:    
Net loss $ (377,939) $ (246,294)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities (64) 68
Foreign currency translation adjustments (2)  
Total other comprehensive income (loss) (66) 68
Comprehensive loss $ (378,005) $ (246,226)